Opis działalności
Headquartered in Basel, Switzerland, Straumann (SIX: STMN) is a global leader in implant, restorative and regenerative dentistry. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and biomaterials for use in tooth replacement and restoration solutions or to prevent tooth loss.
Zarząd & Rada nadzorcza
| CEO |
| Guillaume Daniellot |
| Zarząd |
| Yang Xu, Jason Forbes , Patrick Loh , Alastair Robertson, Sébastien Roche, Aurelio Sahagun, Matthias Schupp, Sara Dalmasso, Thomas Friese, Holger Haderer, Florian Kirsch |
| Rada nadzorcza |
| Petra Rumpf, Dr. Thomas Straumann, Marco Gadola, Regula Wallimann, Xiaoqun Clever-Steg, Stefan Meister, Olivier Filliol |
Dane firmy
| Nazwa: |
Straumann Holding AG |
| Adres: |
Peter Merian-Weg 12,CH-4052 Basel |
| Telefon: |
+41-61-965-1111 |
| Fax: |
+41-61-965-1101 |
| E-mail: |
info@straumann.com
|
| Internet: |
www.straumann.com |
| Przemysł: |
Służba zdrowia |
| Sektor: |
Produkty Medyczne |
| Podsektor: |
Zaawansowane Urządzenia Medyczne |
| Koniec roku finansowego: |
31.12 |
| Free float: |
57,90% |
| Data IPO: |
01.01.1998 |
